Selective serotonin reuptake inhibitors and malformations: case closed?
- PMID: 23228547
- DOI: 10.1016/j.siny.2012.10.004
Selective serotonin reuptake inhibitors and malformations: case closed?
Abstract
Selective serotonin reuptake inhibitors (SSRIs) are widely used by pregnant women due to the high rates of depression among reproductive-age women. Several studies based on administrative databases reported an increased risk of cardiac malformations among infants of pregnant users. This has caused anxiety and fears among expecting women and their physicians, often leading to discontinuation of much-needed therapies. Recent decisive evidence documented a similar higher risk of cardiac malformations among depressed women not taking SSRIs during pregnancy. The most likely reason is ascertainment bias, with depressed women, treated or untreated, undergoing significantly more diagnostic tests in their children. These data strongly support the view that SSRIs do not increase the risk of cardiovascular malformations.
Copyright © 2012. Published by Elsevier Ltd.
Similar articles
-
[Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn].Encephale. 2010 Jun;36 Suppl 2:D133-8. doi: 10.1016/j.encep.2009.06.005. Epub 2009 Sep 19. Encephale. 2010. PMID: 20513456 Review. French.
-
Selective serotonin reuptake inhibitors in pregnancy.Curr Med Chem. 2012;19(27):4554-61. doi: 10.2174/092986712803306349. Curr Med Chem. 2012. PMID: 22876893 Review.
-
Selective Serotonin Reuptake Inhibitors (SSRIs) and the Risk of Congenital Heart Defects: A Meta-Analysis of Prospective Cohort Studies.J Am Heart Assoc. 2015 May 19;4(5):e001681. doi: 10.1161/JAHA.114.001681. J Am Heart Assoc. 2015. PMID: 25991012 Free PMC article.
-
Antidepressant use in pregnancy and the risk of cardiac defects.N Engl J Med. 2014 Jun 19;370(25):2397-407. doi: 10.1056/NEJMoa1312828. N Engl J Med. 2014. PMID: 24941178 Free PMC article.
-
Selective serotonin reuptake inhibitors and congenital malformations.BMJ. 2009 Sep 23;339:b3525. doi: 10.1136/bmj.b3525. BMJ. 2009. PMID: 19776102 No abstract available.
Cited by
-
Patterns and predictors of treatment outcome for antenatal major depression.Singapore Med J. 2017 Nov;58(11):642-648. doi: 10.11622/smedj.2016100. Epub 2016 Jun 1. Singapore Med J. 2017. PMID: 27245863 Free PMC article.
-
Promise and peril: Dissemination of findings from studies of drugs used in pregnancy and their association with birth defects.Birth Defects Res A Clin Mol Teratol. 2015 Aug;103(8):729-32. doi: 10.1002/bdra.23409. Epub 2015 Jul 8. Birth Defects Res A Clin Mol Teratol. 2015. PMID: 26153150 Free PMC article.
-
Echinacea and elderberry-should they be used against upper respiratory tract infections during pregnancy?Front Pharmacol. 2014 Mar 4;5:31. doi: 10.3389/fphar.2014.00031. eCollection 2014. Front Pharmacol. 2014. PMID: 24624087 Free PMC article. Review.
-
Selective serotonin reuptake inhibitor antidepressant use in first trimester pregnancy and risk of specific congenital anomalies: a European register-based study.Eur J Epidemiol. 2015 Nov;30(11):1187-98. doi: 10.1007/s10654-015-0065-y. Epub 2015 Jul 7. Eur J Epidemiol. 2015. PMID: 26148560
-
Ondansetron and pregnancy: Understanding the data.Obstet Med. 2016 Mar;9(1):28-33. doi: 10.1177/1753495X15621154. Epub 2015 Dec 23. Obstet Med. 2016. PMID: 27512487 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
